PKD Cures Act
The PKD Cures Act directs the National Institutes of Health to expand and prioritize research into polycystic kidney disease, a common genetic condition that causes kidney failure in hundreds of thousands of Americans. To achieve this, the bill requires the NIH to intensify studies on the disease's genetic mechanisms, develop new treatments, and create a comprehensive research roadmap involving experts and patient advocates. This roadmap must outline strategies for collaboration, set timelines for innovation, and propose ways to integrate new technologies like artificial medicine into care. Additionally, the legislation mandates that the NIH establish a specialized working group to identify research gaps and submit a detailed report to Congress within 24 months.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jun 2026
Committee Review
Floor Vote
President
Introduced Jun 4, 2026
Last action Jun 4, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Jun 4, 2026
Committee
Referred to the House Committee on Energy and Commerce.
lower
Jun 4, 2026
Introduced
Introduced in House
lower
1 primary · 7 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 9169
Scope: US
Hi! I can help you understand HR 9169. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline